TY - JOUR
T1 - Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS)
AU - Mirmirani, Paradi
AU - Hessol, Nancy A.
AU - Maurer, Toby A.
AU - Berger, Timothy G.
AU - Nguyen, Patricia
AU - Khalsa, Ann
AU - Gurtman, Alejandra
AU - Micci, Sandra
AU - Young, Mary
AU - Holman, Susan
AU - Gange, Stephen J.
AU - Greenblatt, Ruth M.
N1 - Funding Information:
The WIHS is funded by the National Institute of Allergy and Infectious Diseases, with supplemental funding from the National Cancer Institute, the National Institute of Child Health & Human Development, The National Institute of Drug Abuse, the National Institute of Dental Research, the Agency for Health Care Policy and Research, and the Centers for Disease Control and Prevention. Grant numbers U01-AI-35004, U01-AI-31834, U01-AI-34994, U01-AI-34989, U01-HD-32632(NICHD), U01-AI-34993, U01-AI-42590, M01-RR00071, and M01-RR00083.
PY - 2001
Y1 - 2001
N2 - Objective: We attempted to determine the prevalence and predictors of skin disease in a cohort of women with and at risk for HIV infection. Methods. We analyzed baseline data from a multicenter longitudinal study of HIV infection in women. Results: A total of 2018 HIV-infected women and 557 HIV-uninfected women were included in this analysis. Skin abnormalities were reported more frequently among HIV-infected than uninfected women (63% vs 44%, respectively; odds fatio [OR] 2.10; 95% confidence interval [95% CI], 1.74-2.54). Infected women were also more likely to have more than 2 skin diagnoses (OR, 3.27; 95% CI, 1.31-8.16). Folliculitis, seborrheic dermatitis, herpes zoster, and onychomycosis were more common among HIV-infected women (P < .05). Independent predictors of abnormal findings on skin examination in the infected women were African American face (OR, 1.38; 95% CI, 1.07-1.77), injection drug use (OR, 2.74; 95% CI, 2.11-3.57), CD4+ count less than 50 (OR, 1.68; 95% CI, 1.17-2.42), and high viral loads (100,000-499,999 = OR, 1.77; 95% CI, 1.32-2.37; >499,999 = OR, 2.15; 95% CI, 1.42-3.27). Conclusion. HIV infection was associated with a greater number of skin abnormalities and with specific dermatologic diagnoses. Skin abnormalities were also more common among women with CD4+ cell depletion or higher viral load.
AB - Objective: We attempted to determine the prevalence and predictors of skin disease in a cohort of women with and at risk for HIV infection. Methods. We analyzed baseline data from a multicenter longitudinal study of HIV infection in women. Results: A total of 2018 HIV-infected women and 557 HIV-uninfected women were included in this analysis. Skin abnormalities were reported more frequently among HIV-infected than uninfected women (63% vs 44%, respectively; odds fatio [OR] 2.10; 95% confidence interval [95% CI], 1.74-2.54). Infected women were also more likely to have more than 2 skin diagnoses (OR, 3.27; 95% CI, 1.31-8.16). Folliculitis, seborrheic dermatitis, herpes zoster, and onychomycosis were more common among HIV-infected women (P < .05). Independent predictors of abnormal findings on skin examination in the infected women were African American face (OR, 1.38; 95% CI, 1.07-1.77), injection drug use (OR, 2.74; 95% CI, 2.11-3.57), CD4+ count less than 50 (OR, 1.68; 95% CI, 1.17-2.42), and high viral loads (100,000-499,999 = OR, 1.77; 95% CI, 1.32-2.37; >499,999 = OR, 2.15; 95% CI, 1.42-3.27). Conclusion. HIV infection was associated with a greater number of skin abnormalities and with specific dermatologic diagnoses. Skin abnormalities were also more common among women with CD4+ cell depletion or higher viral load.
UR - http://www.scopus.com/inward/record.url?scp=17744363428&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17744363428&partnerID=8YFLogxK
U2 - 10.1067/mjd.2001.112350
DO - 10.1067/mjd.2001.112350
M3 - Article
C2 - 11312425
AN - SCOPUS:17744363428
SN - 0190-9622
VL - 44
SP - 785
EP - 788
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 5
ER -